Sampson, John H <br/><br/>
A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma.  [electronic resource] 

 -  PloS one  2012 
 - e31046 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0031046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Brain Neoplasms--metabolism<br/>CD4-Positive T-Lymphocytes--cytology<br/>CD8-Positive T-Lymphocytes--cytology<br/>Daclizumab<br/>Female<br/>Glioblastoma--metabolism<br/>Humans<br/>Immune System<br/>Immunoglobulin G--pharmacology<br/>Immunosuppressive Agents--pharmacology<br/>Interleukin-2 Receptor alpha Subunit--antagonists & inhibitors<br/>Lymphopenia--metabolism<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>T-Lymphocytes--cytology<br/>T-Lymphocytes, Regulatory--metabolism